Transmission dynamics and economics of rabies control in dogs and humans in an African city

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 35, 2009, Pages 14996-15001

  Zinsstag, J ^a   Durr S ^a   Penny, M A ^a   Mindekem, R ^b   Roth, F ^a   Menendez Gonzalez, S ^c   Naissengar, S ^d   Hattendorf, J ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b Centre de Support en Sante Internationale   (Chad)

^c SWISS FEDERAL VETERINARY OFFICE   (Switzerland)

^d Laboratoire de Recherches Vétérinaire et Zootechnique   (Chad)

Author keywords

[No Author keywords available]

Indexed keywords

RABIES VACCINE;

AFRICA; ARTICLE; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; DOG; DRUG COST; HEALTH ECONOMICS; HUMAN; MASS IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; RABIES;

ANIMALS; CHAD; COST-BENEFIT ANALYSIS; DOG DISEASES; DOGS; FEMALE; HEALTH CARE COSTS; HUMANS; IMMUNIZATION PROGRAMS; MALE; RABIES; RABIES VACCINES; URBAN HEALTH;

ANIMALIA; CANIS FAMILIARIS;

EID: 70349273754     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0904740106     Document Type: Article

References (30)

1. Warrell DA, Warrell MJ (1991) in Infections of the Central Nervous System, Lambert HP, ed (B.C. Decker, Philadelphia), pp 317-328.
2. Knobel DL, et al. (2005) Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 83:360-368.
3. Wandeler AI, Matter HC, Kappeler A, Budde A (1993) The ecology of dogs and canine rabies: a selective review. Rev Sci Tech 12(1):51-71.
4. Hampson K, et al. (2007) Synchronous cycles of domestic dog rabies in sub-Saharan Africa and the impact of control efforts. Proc Natl Acad Sci USA 104:7717-7722. (Pubitemid 47185972)
5. Belotto A, Leanes LF, Schneider MC, Tamayo H, Correa E (2005) Overview of rabies in the Americas. Virus Res 111(1):5-12.
6. Bögel K, Meslin FX (1990) Economics of human and canine rabies elimination: guidelines for programme orientation. Bull World Health Organ 68:281-291. (Pubitemid 20236148)
7. Kayali U, Mindekem R, Hutton G, Ndoutamia AG, Zinsstag J (2006) Cost-description of a pilot parenteral vaccination campaign against rabies in dogs in N'Djamena, Chad. Trop Med Int Health 11:1058-1065. (Pubitemid 44015244)
8. Dürr S, Meltzer M, Mindekem R, Zinsstag J (2008) Owner valuation of rabies vaccination in dogs, Chad. Emerging Infect Dis 14:1650-1652.
9. Cleaveland S, Fevre EM, Kaare M, Coleman PG (2002) Estimating human rabies mortality in the United Republic of Tanzania from dog bite injuries. Bull World Health Organ 80:304-310. (Pubitemid 34492291)
10. Kayali U, et al. (2003) Coverage of pilot parenteral vaccination campaign against canine rabies in N'Djamena, Chad. Bull World Health Organ 81:739-744. (Pubitemid 37429074)
11. Kayali U, et al. (2003) Incidence of canine rabies in N'Djamena, Chad. Prev Vet Med 61:227-233. (Pubitemid 37292967)
12. Dürr S, et al. (2008) Rabies diagnosis for developing countries. PLoS Negl Trop Dis 2(3):e206,1-6.
13. Zinsstag J, et al. (2007) Human benefits of animal interventions for zoonosis control. Emerging Infect Dis 13:527-531. (Pubitemid 46525097)
14. Schwabe CW (1984) Veterinary Medicine and Human Health. (Williams & Wilkins, Baltimore, MD).
15. Akakpo AJ, Mbou G, Bornarel P, Sarradin P, Bada AR (1993) Serologic response in dogs after a mass primary antirabies vaccination (inactivated vaccine) at Pikine Dakar (Senegal) (Translated from French). Dakar Med 38(2):123-128.
16. Chomel B, et al. (1988) Mass vaccination campaign against rabies: are dogs correctly protected? The Peruvian experience. Rev Infect Dis 10 Suppl 4:S697-S702.
17. Bahloul C, et al. (2006) Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions. Vaccine 24:1063-1072. (Pubitemid 43202251)
18. Mindekem R, Kayali U, Yemadji N, Ndoutamia AG, Zinsstag J (2005) Impact of canine demography on rabies transmission in N'Djamena, Chad (Translated from French). Med Trop (Mars) 65(1):53-58.
19. Tan-Torres Edejer T, et al. (2005) Achieving the millenium development goals for health. Cost effectiveness analysis of strategies for child health in developing countries. Br Med J 7C:1-6.
20. Dean DJ, Abelseth MK, Atanasiu P (1996) The fluorescent antibody test. In Meslin FX, Kaplan MM, Koprowski H (Eds.), Laboratory Techniques in Rabies (World Health Organization, Geneva), 4th Ed, p 88-89.
21. WHO (2005) WHO Expert Consultation on Rabies, World Health Organization Tech Rep ser, Geneva, Switzerland, 1-88.
22. Anonymous (2000) Annual Health Statistics of Chad (Translated from French), (Ministry of Health, N'Djamena, Chad) pp. 1-242.
23. Kitala PM, McDermott JJ, Coleman PG, Dye C (2002) Comparison of vaccination strategies for the control of dog rabies in Machakos District, Kenya. Epidemiol Infect 129:215-222.
24. Coleman PG, Fevre EM, Cleaveland S (2004) Estimating the public health impact of rabies. Emerg Infect Dis 10(1):140-142. (Pubitemid 38040708)
25. Anderson R, May R (1991) Infectious Diseases of Humans. (Oxford Univ Press, Oxford, Oxfordshire).
26. Coleman PG, Dye C (1996) Immunization coverage required to prevent outbreaks of dog rabies. Vaccine 14:185-186.
27. Davoust B, Muller G, Chappuis G (1985) Associated vaccinations on dog-serological response to a hexavalent booster vaccine. Revue de Medecine Veterinaire 136:363-372.
28. Murray CJ (1994) Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ 72:429-445.
29. R Development Core Team (2009) R: A language and environment for statistical computing (R Foundation for Statistical Computing, Vienna, Austria).
30. Roth F, et al. (2003) Human health benefits from livestock vaccination for brucellosis: case study. Bull World Health Organ 81:867-876. (Pubitemid 38095336)